.svg){kind=small}
Apr-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
VET CBD's performance across various categories and states shows a mixed picture. In Arizona, the brand has struggled to break into the top 30 for the Edible category, maintaining a rank of 41 for both January and February 2026. This indicates a challenge in gaining market share within this specific category, suggesting potential competitive pressures or a need for strategic adjustments. The absence of a ranking for March and April may imply that VET CBD did not improve its position, which could be a concern for stakeholders focusing on growth in Arizona's edible market.
In contrast, VET CBD has shown remarkable consistency in California's Tincture & Sublingual category, maintaining a solid 5th place ranking from January through April 2026. This stability highlights VET CBD's strong foothold and competitive edge in this category, despite slight fluctuations in monthly sales figures. The consistent ranking suggests that the brand has successfully captured a loyal customer base in California, which could be a foundation for further expansion or product diversification within the state. The sales trend here is worth noting, as it reflects resilience and potential for sustained performance in a highly competitive market.
Competitive Landscape
In the California Tincture & Sublingual category, VET CBD consistently maintained its 5th rank from January to April 2026, showcasing a stable position in a competitive market. Despite a slight dip in sales from January to February, VET CBD's sales rebounded in March and remained robust through April. This stability is notable given the competitive pressure from brands like ABX / AbsoluteXtracts, which fluctuated between 6th and 7th positions, and Proof, which improved its rank from 8th to 7th by April. Yummi Karma and Care By Design consistently outperformed VET CBD, holding higher ranks at 2nd and 4th, respectively, with Yummi Karma showing particularly strong sales figures. VET CBD's consistent ranking amidst these dynamics suggests a solid brand presence, though opportunities for growth may lie in strategies to close the sales gap with higher-ranked competitors.
Notable Products
In April 2026, the CBD/THC 20:1 Regular Strength Tincture (125mg CBD, 6.25mg THC, 1oz, 30ml) maintained its position as the top-performing product for VET CBD, with sales reaching 960 units. The CBD/THC 20:1 Regular Strength Tincture (250mg CBD, 12.5mg THC, 60ml, 2oz) followed closely, consistently holding the second rank from February through April. The CBD/THC 20:1 Regular Strength Tincture (1000mg CBD, 50mg THC, 2oz, 60ml) improved its position from fourth in March to third in April, showcasing a positive trend in sales. Meanwhile, the CBD/THC 20:1 Extra Strength Pet Tincture (250mg CBD, 25mg THC, 60ml, 2oz) re-entered the rankings in April at fourth place, reflecting a renewed interest in pet products. The CBD/THC 10:1 Extra Strength Tincture (500mg CBD, 50mg THC, 60ml, 2oz) dropped from third to fifth, indicating a decrease in consumer demand compared to previous months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
